HLAVNÍ TÉMA Covid-19 u nemocných po transplantaci ledviny 448 | VNITŘNÍ LÉKAŘSTVÍ / Vnitř Lék. 2022;68(7):444-448 / www.casopisvnitrnilekarstvi.cz LITERATURA 1. Information on COVID-19 Treatment, Prevention and Research. COVID-19 Treatment Gui‑ delines. [cited June 2022]. Avalible from: https://www.covid19treatmentguidelines.nih.gov/ 2. Gottlieb RL, Vaca CE, Paredes R et al. Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients. N Engl J Med. 2022;386(4):305-315. 3. Ackley TW, McManus D, Topal JE, Cicali B, Shah S. A Valid Warning or Clinical Lore: an Evaluation of Safety Outcomes of Remdesivir in Patients with Impaired Renal Function from a Multicenter Matched Cohort. Antimicrob Agents Chemother. 2021;65(2):e02290-20. 4. Jayk Bernal A, Gomes da Silva MM, Musungaie DB et al. Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients. N Engl J Med. 2022;386(6):509-520. 5. Takashita E, Kinoshita N, Yamayoshi S, et al. Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant. N Engl J Med. 2022;386(10):995-998. 6. Hammond J, Leister‑Tebbe H, Gardner A et al. Oral Nirmatrelvir for High‑Risk, Nonhospitali‑ zed Adults with Covid-19. N Engl J Med. 2022;386(15):1397-1408. doi:10.1056/NEJMoa2118542. 7. Beigel JH, Tomashek KM, Dodd LE et al. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020;383(19):1813-1826. 8. RECOVERY Collaborative Group, Horby P, LimWS et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384(8):693-704. 9. Prendecki M, Clarke C, Gleeson S et al. Detection of SARS‑CoV-2 Antibodies in Kidney Transplant Recipients. J Am Soc Nephrol. 2020;31(12):2753-2756. 10. Magicova M, Fialova M, Zahradka I et al. Humoral response to SARS‑CoV-2 is well preserved and symptom dependent in kidney transplant recipients. Am J Transplant. 2021;21(12):3926-3935. 11. Bertrand D, Hamzaoui M, Drouot L et al. SARS‑CoV-2-specific Humoral and Cellular Im‑ munities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19. Transplant Direct. 2021;7(12):e792. 12. Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody Response to 2-Dose SARS‑CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. JAMA. 2021;325(21):2204-2206. 13. Magicova M, Zahradka I, Fialova M et al. Determinants of Immune Response to Anti ‑SARS‑CoV-2 mRNA Vaccines in Kidney Transplant Recipients: A Prospective Cohort Stu‑ dy. Transplantation. 2022;106(4):842-852. 14. Chavarot N, Ouedrani A, Marion O et al. Poor Anti‑SARS‑CoV-2 Humoral and T‑cell Re‑ sponses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept. Transplantation. 2021;105(9):e94-e95. 15. Li P, Wang Y, Lavrijsen M et al. SARS‑CoV-2 Omicron variant is highly sensitive to mol‑ nupiravir, nirmatrelvir, and the combination. Cell Res. 2022;32(3):322-324. 16. Aslam S, Adler E, Mekeel K, Little SJ. Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients. Transpl Infect, DiS. 2021;23(5):e13705. 17. Zahradka I, Petr V, Modos I, Magicova M, Dusek L, Viklicky O. Association Between SARS‑CoV-2 Messenger RNA Vaccines and Lower Infection Rates in Kidney Transplant Re‑ cipients : A Registry‑Based Report [published online ahead of print, 2022 May 3]. Ann In‑ tern Med. 2022;M21-2973. 18. Callaghan CJ, Mumford L, Curtis RMK et al. Real‑world Effectiveness of the Pfizer ‑BioNTech BNT162b2 and Oxford‑AstraZeneca ChAdOx1-S Vaccines Against SARS‑CoV-2 in Solid Organ and Islet Transplant Recipients. Transplantation. 2022;106(3):436-446. 19. Bruxvoort KJ, Sy LS, Qian L et al. Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS‑CoV-2: test negative case‑control study. BMJ. 2021;375:e068848. Published 2021 Dec 15. 20. Andrews N, Stowe J, Kirsebom F et al. Covid-19 Vaccine Effectiveness against the Omicron (B.1. 1. 529) Variant. N Engl J Med. 2022;386(16):1532-1546. ODBORNÝ GARANT prof. MUDr. David Karásek, Ph.D. Průběžně aktualizovaný program a registrace: www.diabetologiepropraxi.cz POŘADATEL: SOLEN, s. r. o., ve spolupráci se III. interní klinikou – nefrologickou, revmatologickou a endokrinologickou FN Olomouc AKCE SE USKUTEČNÍ prezenčně v Hotelu Flora Olomouc diabetologie pro praxi 26. 1. 2023 HOTEL FLORA, OLOMOUC 1. TEMATICKÉ BLOKY: DIABETES MELLITUS… …a kardiologie prof. MUDr. David Karásek, Ph.D. …a uro-gynekologická problematika doc. MUDr. Taťána Šrámková, CSc. …jako psychosomatický problém prof. MUDr. Kateřina Štechová, Ph.D. …a novinky ve farmakoterapii ... a jaterní poškození prof. MUDr. Petr Husa, CSc. DISKUZNÍ PANEL: Obezita doc. MUDr. Ľubica Cibičková, Ph.D.
RkJQdWJsaXNoZXIy NDA4Mjc=